FDA ARTHRITIS ADVISORY-COMMITTEE MEETING - RISKS OF AGRANULOCYTOSIS APLASTIC-ANEMIA, FLANK PAIN, AND ADVERSE GASTROINTESTINAL EFFECTS WITH THE USE OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS

被引:15
作者
PAULUS, HE
机构
来源
ARTHRITIS AND RHEUMATISM | 1987年 / 30卷 / 05期
关键词
D O I
10.1002/art.1780300518
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:593 / 595
页数:3
相关论文
共 4 条
[1]  
FAICH GA, 1986, JAMA-J AM MED ASSOC, V256, P1788
[2]   STUDY OF FATAL BONE-MARROW DEPRESSION WITH SPECIAL REFERENCE TO PHENYLBUTAZONE AND OXYPHENBUTAZONE [J].
INMAN, WHW .
BRITISH MEDICAL JOURNAL, 1977, 1 (6075) :1500-1505
[3]   FDA ARTHRITIS ADVISORY-COMMITTEE MEETING [J].
PAULUS, HE .
ARTHRITIS AND RHEUMATISM, 1985, 28 (04) :450-451
[4]  
The International Agranulocytosis and Aplastic Anemia Study, 1986, JAMA, V256, P1749